SNSE NASDAQ
Sensei Biotherapeutics, Inc.
1W: +6.5%
1M: -30.1%
3M: -53.7%
YTD: +43.5%
1Y: +106.4%
3Y: -49.5%
5Y: -94.3%
$13.85
Last traded 2026-06-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$22M
+29.6% ▲
Net Income
-$21M
+30.1% ▲
EPS (Diluted)
$-16.72
-1293.3% ▼
EBITDA
-$22M
+24.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $685K | $2M | $571K | $551K | $0 |
| Gross Profit | -$685K | -$2M | -$571K | -$551K | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $22M | $30M | $18M | $19M | $11M |
| SG&A Expenses | $15M | $18M | $19M | $12M | $11M |
| Operating Expenses | $37M | $47M | $36M | $31M | $22M |
| Operating Income | -$37M | -$49M | -$37M | -$32M | -$22M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $670K | $219K | $144K | $90K | -$32K |
| Income Before Tax | -$37M | -$49M | -$34M | -$30M | -$21M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$37M | -$49M | -$34M | -$30M | -$21M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.33 | $-1.58 | $-1.22 | $-1.20 | $-16.72 |
| EBITDA | -$35M | -$47M | -$33M | -$30M | -$22M |
| Shares Outstanding | 28M | 31M | 28M | 25M | 1M |